WallStreetZenWallStreetZen

NASDAQ: MURA
Mural Oncology PLC Earnings & Revenue

MURA earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$207.4M
Current Profit Margin
0%

MURA Return on Equity

Current Company
-171.3%
Current Industry
-63.5%
Current Market
188.7%
MURA's Return on Equity (-171.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MURA announces earnings.

MURA Return on Assets

Current Company
-123.7%
Current Industry
2.9%
MURA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MURA Return on Capital Employed

Current Company
-71.61%
Current Industry
19.5%

MURA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MURA$0.00-$192.72M-$207.45MN/AN/A
EQ$36.08M-$12.14M-$13.34M+128.97%N/A
KRON$6.29M-$107.76M-$112.67MN/AN/A
THTX$57.43M-$1.41M-$13.23M+4.98%N/A
ALGS$15.53M-$85.06M-$87.68M+88.75%N/A

Mural Oncology Earnings & Revenue FAQ

What were MURA's earnings last quarter?

Mural Oncology (NASDAQ: MURA) reported Q4 2023 earnings per share (EPS) of -$3.57, up 22.68% year over year. Total Mural Oncology earnings for the quarter were -$59.54 million. In the same quarter last year, Mural Oncology's earnings per share (EPS) was -$2.91.

If you're new to stock investing, here's how to buy Mural Oncology stock.

What was MURA's earnings growth in the past year?

As of Q2 2024, Mural Oncology's earnings has grown year over year. Mural Oncology's earnings in the past year totalled -$207.45 million.

What was MURA's revenue last quarter?

Mural Oncology (NASDAQ: MURA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Mural Oncology's revenue was $0.00.

What was MURA's revenue growth in the past year?

As of Q2 2024, Mural Oncology's revenue has grown null year over year. Mural Oncology's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.